Cargando…

Consistent analysis of differentially expressed genes across 7 cell types in papillary thyroid carcinoma

Single-cell transcriptome sequencing (scRNA-seq) provides a higher resolution of cellular differences than bulk RNA-seq, enabling the dissection of cell-type-specific responses to perturbations in papillary thyroid carcinoma (PTC). However, cellular genomic features are highly heterogeneous and have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Xianhui, Huang, Yue, Geng, Lin, Tian, Mengran, Liu, Yu, Tao, Mei, Zheng, Xiangqian, Li, Peng, Zhao, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637855/ https://www.ncbi.nlm.nih.gov/pubmed/37954148 http://dx.doi.org/10.1016/j.csbj.2023.10.045

Ejemplares similares

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
por: Hu, Linfei, et al.
Publicado: (2022)

Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles
por: Wei, Songfeng, et al.
Publicado: (2019)

Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer
por: Zeng, Yu, et al.
Publicado: (2023)

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
por: Gu, Pengfei, et al.
Publicado: (2022)

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments
por: Sun, Ying, et al.
Publicado: (2022)

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer
por: Ma, Weike, et al.
Publicado: (2023)

High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion
por: Zhao, Jingzhu, et al.
Publicado: (2019)

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
por: Hou, Xiukun, et al.
Publicado: (2021)

Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway
por: Zhao, Zewei, et al.
Publicado: (2022)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Diagnosis and treatment of ectopic thyroid carcinoma: A case report and literature review
por: Fu, Guiming, et al.
Publicado: (2022)

Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer
por: Tang, Tao, et al.
Publicado: (2022)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Ultrasonographic, clinical, and pathological features of papillary thyroid carcinoma in children and adolescents with or without Hashimoto’s thyroiditis
por: Jie, Yue, et al.
Publicado: (2023)

Functional analysis and clinical significance of the isocitrate dehydrogenase 2 gene in papillary thyroid carcinoma
por: Zhang, Jun, et al.
Publicado: (2019)

Active surveillance as a management strategy for papillary thyroid microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2020)

Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma
por: Zhang, Bo, et al.
Publicado: (2016)

TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021)

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
por: Meng, Xiangrui, et al.
Publicado: (2020)

Comparison of ultrasonography and pathology features between children and adolescents with papillary thyroid carcinoma
por: Jie, Yue, et al.
Publicado: (2023)

The intratumor microbiome predicts prognosis across gender and subtypes in papillary thyroid carcinoma
por: Gnanasekar, Aditi, et al.
Publicado: (2021)

Synchronous primary hyperparathyroidism, follicular thyroid carcinoma, and papillary thyroid carcinoma
por: Dai, Dong-Jun, et al.
Publicado: (2019)

Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells
por: Penha, Ricardo Cortez Cardoso, et al.
Publicado: (2018)

Genetic Alterations in Papillary Thyroid Carcinoma With Hashimoto(’)s Thyroiditis： ANK3, an Indolent Maintainer of Papillary Thyroid Carcinoma
por: Zeng, Chao, et al.
Publicado: (2022)

Thyroid papillary carcinoma associated to Hashimoto's thyroiditis
por: Campos, Luiz Alexandre Albuquerque Freixo, et al.
Publicado: (2015)

Identification of Differentially Expressed Genes in Papillary Thyroid Cancers
por: Lee, Ki-Young, et al.
Publicado: (2009)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

P2X(7) Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis
por: Kwon, Ji Hyun, et al.
Publicado: (2014)

Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma
por: Liu, Mei-juan, et al.
Publicado: (2017)

Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma
por: Affinito, Ornella, et al.
Publicado: (2022)

Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma
por: Han, Jun, et al.
Publicado: (2018)

Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography
por: Peng, Chanjuan, et al.
Publicado: (2022)

Integrin β4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus
por: Li, Jian, et al.
Publicado: (2019)

Discovery and identification of potential biomarkers of papillary thyroid carcinoma
por: Fan, Yuxia, et al.
Publicado: (2009)

PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause
por: Hou, Xiukun, et al.
Publicado: (2023)

Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors
por: Chi, Jiadong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hu8ccu0d3j09g71ge8hsh04bls